Production (Stage)
Bio-Techne Corporation
TECH
$46.78
-$0.54-1.14%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -53.96% | 27.03% | -34.11% | -46.23% | -30.14% |
| Total Depreciation and Amortization | 0.95% | -2.59% | -1.41% | -6.71% | 1.26% |
| Total Amortization of Deferred Charges | -- | -- | -- | 5.19% | -- |
| Total Other Non-Cash Items | 4.99% | 12.19% | 6,972.25% | 309.84% | 145.25% |
| Change in Net Operating Assets | -1,038.32% | -35.05% | 51.26% | 5.84% | 103.38% |
| Cash from Operations | -49.23% | 1.48% | 7.59% | -9.47% | 60.26% |
| Capital Expenditure | 38.43% | 54.11% | 32.52% | -66.00% | -39.95% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 100.00% | -148.29% | 50.98% | 100.00% |
| Cash from Investing | 46.03% | 78.74% | 85.93% | -85.20% | 93.18% |
| Total Debt Issued | -- | -- | -- | -- | -100.00% |
| Total Debt Repaid | 86.21% | 100.00% | 72.86% | -250.00% | -- |
| Issuance of Common Stock | -18.87% | 5.00% | 74.39% | 172.57% | 314.54% |
| Repurchase of Common Stock | -59,624.40% | 5.52% | 75.36% | -930.77% | 98.47% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -0.01% | -1.41% | -0.27% | -0.24% | 0.02% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -29.82% | -3.00% | -116.18% | -148.10% | -134.75% |
| Foreign Exchange rate Adjustments | 53.92% | -259.74% | 158.84% | 569.18% | -201.03% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -476.97% | 46.08% | 212.04% | -77.71% | 126.16% |